The MarkeTech Group (TMTG) conducted a poll of its imagePRO opt-in panel of more than 600 U.S.-hospital based imaging administrative directors and managers. Manuel Andrade, TMTG's reserach analyst, made the analysis.
Q: How will the change in reimbursement change your institution's current use of PET/CT imaging?
A: Most respondents believe the change in reimbursement will have no impact in the use of PET/CT.
July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...
July 02, 2024 
June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...
June 18, 2024 
June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...
June 14, 2024 
June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...
June 10, 2024 
May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...
May 14, 2024 
April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...
April 23, 2024 
January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...
January 23, 2024 
January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...
January 22, 2024 
December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...
December 27, 2023 
December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...
December 06, 2023